The Food and Drug Administration has approved a new drug to treat advanced pancreatic cancer. This breakthrough could potentially extend the survival of patients with metastatic pancreatic cancer.

The approval was made on Wednesday, marking a significant development for those affected by this condition.

Further details about the drug and its potential impact are available from the source, providing more information on this medical advancement.